tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CMMB Stock Latest News

Chemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
The FlyChemomab Therapeutics price target raised to $25 from $10 at Oppenheimer
10d ago
CMMB
Chemomab Therapeutics Ltd – ADR trading halted, news pending
PremiumThe Fly
Chemomab Therapeutics Ltd – ADR trading halted, news pending
12d ago
CMMB
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested
14d ago
OP
QH
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
PremiumCompany Announcements
Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025
15d ago
6K
CMMB
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
PremiumRatings
Chemomab Therapeutics: Advancing CM-101 with Strategic Financial Optimizations and FDA Support
22d ago
CMMB
Chemomab Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsChemomab Therapeutics Reports Q2 2025 Financial Results
24d ago
6K
CMMB
Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year
Premium
The Fly
Chemomab Therapeutics reports Q2 EPS 0.4c vs 0.013c last year
24d ago
CMMB
Chemomab Therapeutics management to meet with Maxim
Premium
The Fly
Chemomab Therapeutics management to meet with Maxim
1M ago
CMMB
Chemomab Therapeutics Enters Sales Agreement with LifeSci Capital
PremiumCompany Announcements
Chemomab Therapeutics Enters Sales Agreement with LifeSci Capital
1M ago
6K
CMMB
Chemomab Therapeutics Announces Key Decisions from Annual Shareholders Meeting
PremiumCompany Announcements
Chemomab Therapeutics Announces Key Decisions from Annual Shareholders Meeting
2M ago
6K
CMMB
Chemomab Therapeutics announces data from Phase 2 SPRING trial of nebokitug
PremiumThe Fly
Chemomab Therapeutics announces data from Phase 2 SPRING trial of nebokitug
2M ago
CMMB
Chemomab obtained feedback from two recent FDA meetings on nebokitug
PremiumThe Fly
Chemomab obtained feedback from two recent FDA meetings on nebokitug
3M ago
CMMB
Chemomab announces nebokitug awarded new patent protection in China, Russia
PremiumThe FlyChemomab announces nebokitug awarded new patent protection in China, Russia
3M ago
CMMB
Chemomab Therapeutics Announces Annual General Meeting for July 2025
Premium
Company Announcements
Chemomab Therapeutics Announces Annual General Meeting for July 2025
3M ago
6K
CMMB
Chemomab Therapeutics: Promising Prospects with Streamlined Path to Approval and Strategic Advancements
Premium
Ratings
Chemomab Therapeutics: Promising Prospects with Streamlined Path to Approval and Strategic Advancements
4M ago
CMMB
Chemomab Therapeutics Advances Nebokitug for PSC Treatment
PremiumCompany Announcements
Chemomab Therapeutics Advances Nebokitug for PSC Treatment
4M ago
CMMB
Chemomab Therapeutics price target lowered to $10 from $11 at Oppenheimer
PremiumThe Fly
Chemomab Therapeutics price target lowered to $10 from $11 at Oppenheimer
4M ago
CMMB
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
PremiumCompany Announcements
Chemomab Therapeutics Advances Nebokitug Towards Phase 3 After Positive Trial Results
4M ago
6K
CMMB
Chemomab Therapeutics reports Q1 EPS $0.007 vs $0.014 last year
PremiumThe Fly
Chemomab Therapeutics reports Q1 EPS $0.007 vs $0.014 last year
4M ago
CMMB
Chemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
PremiumRatingsChemomab Therapeutics: Promising Phase 2 Data and Attractive Entry Point Justify Buy Rating
4M ago
CMMB
Chemomab Therapeutics announces presentation of Phase 2 data of CM-101
Premium
The Fly
Chemomab Therapeutics announces presentation of Phase 2 data of CM-101
4M ago
CMMB
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
NVS
BCDA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >